Late Breaking Clinical Trial

Effects of Interleukin6 Inhibition with Ziltivekimab on Biomarkers of Inflammation and Thrombosis Among Patients at High Atherosclerotic Risk A Randomized DoubleBlind Phase 2 Trial Paul Ridker Matt Devalaraja Florian Baeres Mads Engelmann G Kees Hovingh Milana Ivkovic Larry Lo Douglas Kling Pablo Pergola Dominic Raj Peter Libby and Michael Davidson

Embed this Presentation

Download Notice

Download Presentation The PPT/PDF document "Late Breaking Clinical Trial" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.